We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Acid-Sensitive Nanoparticle Drug Delivery System Targets Cancer Stem Cells

By LabMedica International staff writers
Posted on 22 Jun 2015
Print article
Image: After two hours, doxorubicin-carrying nanoparticles accumulated in cancer cells (red and yellow) in mice (left) and destroyed most of the tumor within a day (right) (Photo courtesy of the American Chemical Society).
Image: After two hours, doxorubicin-carrying nanoparticles accumulated in cancer cells (red and yellow) in mice (left) and destroyed most of the tumor within a day (right) (Photo courtesy of the American Chemical Society).
A novel nanoparticle-based drug delivery system was designed to destroy the cancer stem cells that are responsible for tumor recurrence and development of drug resistance.

Drug resistant cancer stem-like cells are responsible for cancer recurrence associated with conventional chemotherapy. To target this class of cells, investigators at The Ohio State University (Columbus, USA) developed a novel type of doxorubicin (DOX)-encapsulated polymeric nanoparticles.

Although in use for more than 40 years as a primary chemotherapy drug, DOX is known to cause serious heart problems. To prevent these, doctors may limit the amount of DOX given to each patient so that the total amount a patient receives over her or his entire lifetime is 550 milligrams per square meter, or less. Furthermore, the necessity to stop treatment to protect the patient from heart disease may diminish the usefulness of DOX in treating cancer.

The surface of the DOX nanoparticles was "decorated" with chitosan, a natural polysaccharide that guided the particles to the CD44 receptors on the cancer stem cells.

Chitosan is muco-adhesive in nature, reactive (so it can be produced in many different forms), and has a positive charge under acidic conditions. This positive charge comes from protonation of its free amino groups. Lack of a positive charge means chitosan is insoluble in neutral and basic environments. However, in acidic environments, protonation of the amino groups leads to an increase in solubility. The implications of this are very important to biomedical applications. This molecule will maintain its structure in a neutral environment, but will solubilize and degrade in an acidic environment. This means chitosan can be used to transport a drug to an acidic environment, such as the tumor microenvironment, where the chitosan packaging will then degrade, releasing the drug.

Results published in the May 25, 2015, online edition of the journal ACS Nano revealed that the nanoparticle design strategy increased the apparent cytotoxicity of doxorubicin by six times in comparison to the use of the free drug for eliminating CD44+ cancer stem-like cells residing in cultured three-dimensional mammary tumor spheroids. They further showed that the nanoparticles reduced the size of tumors in a mouse orthotopic xenograft tumor model with no evident systemic toxicity.

The investigators concluded that further development of the nanoparticle system to target cancer stem-like cells with low systemic toxicity could provide a new treatment arsenal for improving the survival of cancer patients.

Related Links:

The Ohio State University


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Thyroid ELISA Kit
AESKULISA a-TPO
New
Incubator
HettCube 120

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.